303-19: Pharmacological Management of Alzheimer’s Disease and Other Neurocognitive Disorders

4.83 (12 votes)

303-19:  Pharmacological Management of Alzheimer’s Disease and Other Neurocognitive Disorders 

Delve into key considerations for making pharmacologic decisions across Alzheimer’s disease and other neurocognitive disorders. Use a holistic methodology to ensure patient-centered care that encompasses family and support factors.

  Pamela Z. Cacchione, PhD, CRNP, BC, FGSA, FAAN

Disclosures:  The speaker has indicated a significant financial interest or other affiliation with Clinical Nursing Research (royalties). Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

Session Length:
  1 hour 27 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  1. Identify appropriate medications for persons with Alzheimer’s disease and other neurocognitive disorders.
  2. Discuss informed consent from responsible parties for the use of medications in Alzheimer’s disease and other neurocognitive disorders.

Keywords:  Psychopharmacology, Alzheimer’s Disease

Continuing Nursing Education:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented:
APNA 17th Annual Clinical Psychopharmacology Institute
Louisville, KY
Sunday, June 9, 2019
12:15pm - 1:45pm

The contact hours for this session expire:  June 30, 2021

Components visible upon registration.